The plaques are not the problem - been proven for 20 years that you can remove all the soluble and insoluble beta amyloid and there is no clinical benefit but because beta amyloid chains integrate into blood vessels, there is cranial hemorrhaging. This mAb is no different and should not have been approved, IMO.